| Trial ID: | L0399 |
| Source ID: | NCT01302236
|
| Associated Drug: |
Eplerenone
|
| Title: |
Effect of Eplerenone in Elderly Hypertensive Early Stage Chronic Kidney Disease (CKD) Patients
|
| Acronym: |
|
| Status: |
WITHDRAWN
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Hypertension|Chronic Kidney Disease.
|
| Interventions: |
DRUG: Eplerenone
|
| Outcome Measures: |
Primary: The change of heart function confirmed by echocardiograph and plasma level of BNP, 6 months|The change of renal function confirmed by eGFR and proteinuria., 6 months | Secondary: The change of blood pressure, The change of systolic blood pressure and diastolic blood pressure, 6 months|The change of oxidative stress markers confirmed by plasma level of 8-OHdG and d-ROM, 6 months
|
| Sponsor/Collaborators: |
Sponsor: Jichi Medical University
|
| Gender: |
ALL
|
| Age: |
OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
0
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2011-03
|
| Completion Date: |
2012-07
|
| Results First Posted: |
|
| Last Update Posted: |
2012-07-06
|
| Locations: |
|
| URL: |
https://clinicaltrials.gov/show/NCT01302236
|
